
    
      A Phase I, Single Centre, Open, Partly Randomised, Crossover Study in Healthy Subjects to
      Evaluate AZD5423 Absolute Pulmonary Bioavailability when Administered Inhaled via a New Dry
      Powder Inhaler, Turbuhaler, Spira nebulizer and I-neb AAD system
    
  